MB3057 Antimicrobial drug resistance a global threat 1 - Oggioni

Page 1: Overview of Antimicrobial Drug Resistance

  • Title: MB3057 Antimicrobial drug resistance: a global threat

  • Presenter: Marco R. Oggioni, Department of Genetics and Genome Biology, University of Leicester

Page 2: Drug Targets and Resistance

  • Drug Target Characteristics:

    • Selective for bacterial cells.

    • Essential for bacterial replication and survival.

    • Mechanisms common to most bacterial cells (broad spectrum).

  • Resistance Factors:

    • Drug resistance reduces the activity spectrum (narrow spectrum).

    • Antimicrobial drug use selects for drug resistance.

  • Types of Antimicrobial Agents:

    • Antibiotics (e.g., penicillin): high selectivity, systemic use.

    • Antiseptics (e.g., chlorhexidine): reasonable selectivity, topical use.

    • Disinfectants (e.g., sodium hypochlorite): low selectivity, environmental use.

  • Key Points:

    • Most agents target bacteria; fewer target fungi, viruses, protozoa, and helminths.

    • Clinical antimicrobial agents do not affect bacterial spores, fungi spores, or latent viruses.

    • Major Groups:

      • β-lactam compounds (e.g., penicillins, cephalosporins): semisynthetic derivatives with varied properties.

      • Other antibacterial agents: aminoglycosides, tetracyclines, macrolides, glycopeptides, quinolones.

Page 3: Phylogenetic Tree of Cellular Life

  • Domains of Life:

    • Bacteria, Archaea, Eucarya.

  • Classification Examples:

    • Examples of specific organisms across the spectrum of life, such as:

      • Green nonsulfur bacteria

      • Methanosarcina (Archaea)

      • Eucarya examples like animals and plants.

Page 4 & 5: Antibacterial Targets - Macromolecular Structures

  • Macromolecular Structures:

    • Targets include ribosomes (30S and 50S), RNA polymerase, or DNA gyrase.

  • Antibacterial Agents:

    • Examples with specific targets:

      • Tetracycline (30S)

      • Penicillin (cell wall)

      • Rifampicin (RNA polymerase)

      • Ciprofloxacin (DNA gyrase).

Page 6: Principal Types of Antibacterial Agents

  • Focus on antibacterial agents excluding those for mycobacterial infections.

Page 7: Clinical Activity Overview

  • Agents and Their Clinical Activity Against Bacteria:

    • Detailed activity against various bacterial strains:

      • Penicillins: Cell wall agents effective against multiple bacteria.

      • Cephalosporins: Effective against similar bacteria to penicillins.

      • Tetracyclines: Ribosome-targeting agents effective against a variety.

    • Other specific agents listed with their spectrum of activity.

Page 8: Inhibitors of Cell Wall Synthesis

  • Mechanism of Action:

    • Glycopeptides such as vancomycin are effective against Gram-positive organisms with multiple resistances.

Page 9: Molecular Structures of β-Lactam Antibiotics

  • Examples:

    • Various penicillins like ampicillin and cephalosporins like cefuroxime.

    • Characteristics and resistance abilities of some agents highlighted.

Page 10: Penicillin Allergies

  • Allergy Overview:

    • Significant proportion of anaphylaxis deaths related to penicillin.

    • Testing and cross-reactivity information.

Page 11: Protein Synthesis Inhibitors

  • Overview of various inhibitors affecting ribosomal activity including:

    • Tetracyclines: Broad-spectrum agents.

    • Chloramphenicol: Broad antibacterial spectrum but with serious side effects.

    • Aminoglycosides: Risk of toxicity highlighted.

    • Macrolides: Effective against specific bacterial infections.

Page 12: Inhibitors of Nucleic Acid Synthesis

  • Classes of Inhibitors:

    • Sulphonamides & Diaminopyrimidines: Block folic acid biosynthesis.

    • Quinolones: Target DNA gyrase, often used for urinary tract infections.

Page 13: Cell Membrane Disruption

  • Mechanisms:

    • Polymyxins: Disrupt bacterial cell membranes; often used as last resort agents.

    • Daptomycin: Effective against resistant Gram-positive organisms.

Page 14: Learning Summary - Lecture 1

  • Key Concepts:

    • Antimicrobial drugs demonstrate selective bacterial activity.

    • Drug discovery pipeline is concerningly empty; big pharma has shifted focus.

Page 15: Part 2 - Antimicrobial Drug Discovery

  • Overview of the continued challenges and focuses in drug discovery.

Page 16: Antibiotic Discovery Timeline

  • Overview of new antibacterial agents approved from 1983 to 2003.

Page 17: Relevant Classes of Antibiotics

  • Natural Product-Derived Antibiotics:

    • Examples include penicillins, cephalosporins, macrolides, etc.

Page 18: Folic Acid Biosynthesis

  • Comparison of folic acid biosynthesis pathways in humans vs. Neisseria.

    • Significance of pathway differences for drug targeting.

Page 19: New Antibiotic Discovery

  • Focus on Darobactin:

    • Innovations and discoveries related to targeting Gram-negative bacteria.

Page 20: Deep Learning in Antibiotic Discovery

  • Use of AI to discover new antibacterial compounds.

  • Highlights successful identification of effective molecules through deep learning.

Page 21: Summary of Deep Learning Studies

  • Reinforces the successes and future possibilities of AI in discovering novel antibacterial agents.

Page 22: Future Directions in Antibiotic Research

  • New targets/approaches, screening methods, and the role of bacteriophages.

  • Emphasis on antimicrobial stewardship and preventive measures.

Page 23: Learning Summary - Lecture 2

  • Recap of essential points regarding AMR and its implications for therapeutic choices.

  • The alarming rise of AMR statistics and projections for the future.